Disclosure of voting rights for Chairman of the Board
24 Mayo 2022 - 3:44AM
Disclosure of voting rights for Chairman of the Board
Oslo, 24 May 2022. PCI Biotech Holding ASA ("PCI
Biotech" or the "Company") issue this notification on behalf of its
chairman, Hans Peter Bøhn.
Hans Peter Bøhn is chairman of PCI Biotech and
shall open the annual general meeting of the Company on 25 May
2022. Mr. Bøhn holds 123,662 shares, representing 0.3 per cent of
the share capital of PCI Biotech. Mr. Bøhn has received powers of
attorney to represent and vote for 7,234,249 additional shares. In
total, Mr. Bøhn will represent and vote for 19.7 per cent of the
share capital. A major part of the powers of attorney are without
voting instructions. The powers of attorney are only valid at the
annual general meeting on 25 May 2022.
This information is subject to the disclosure
requirements pursuant to section 4 -3, cf. section 5-12 of the
Norwegian Securities Trading Act.
Contact
information: PCI
Biotech Holding ASA, Ullernchausséen 64, N-0379
Oslo Ronny
Skuggedal, CFO, rs@pcibiotech.no, Mobile: +47 9400 5757
Pci Biotech Holding Asa (LSE:0JGL)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Pci Biotech Holding Asa (LSE:0JGL)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024